New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 2, 2013
06:43 EDTBCRC.R. Bard upgraded to Overweight from Neutral at JPMorgan
JPMorgan upgraded C.R. Bard based on expectations for a resolution of the Gore patent litigation, a positive outcome in the LEVANT 2 trial, and higher earnings revisions. Price target raised to $116 from $110.
News For BCR From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
January 28, 2016
16:26 EDTBCRC.R. Bard sees 2016 adjusted EPS $9.90-$10.05, consensus $9.89
Subscribe for More Information
16:25 EDTBCRC.R. Bard reports Q4 adjusted EPS $2.43, consensus $2.41
Reports Q4 revenue $870.8M, consensus $867.58M.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use